Notes from H-100:

New residents and fellows joining us for the upcoming academic year:

Incoming Residents:

Ahmet Altiner MD is a graduate of NYU School of Medicine where he is completing an internship in internal medicine

Jeremy Brauer MD a graduate of the University of Pennsylvania, completing an internship in internal medicine at Lenox Hill

Mercedes Gonzalez MD is a graduate of UMDNJ, and has completed a Pediatric Residency at Columbia's Morgan Stanley Children's Hospital and a research fellowship in Pediatric Dermatology at the University of Miami

Rachael Hartman MD MBA is a graduate of Columbia's College of Physicians and Surgeons, and joins us after completing her internship in internal medicine at Northwestern University in Chicago

Ali Jabbari MD PhD an graduate of the University of Iowa's MSTP program, is completing a Medicine internship UT Southwestern/Parkland Memorial in Dallas

Gideon Smith MD PhD is a graduate of Weill Cornell School of Medicine and is completing an internship in internal medicine at Beth Israel Medical Center in NYC

Brook Tlougan MD, is a graduate of the University of Arizona where he was also an intern. He's completing a research fellowship in Pediatric Dermatology at Northwestern in Chicago

Melanie Warycha MD, a graduate of NYU School of Medicine has most recently been the Melanoma Research Fellow at NYU School of Medicine

Dermatopathology Fellows:
Wang (Steve) Leung Cheung, M.D. Ph.D., a graduate of the University of Virginia School of Medicine where he also obtained his Ph.D. in Microbiology, is completing his Pathology training at Johns Hopkins; Rishi R. Patel, M.D. a graduate of Case Western Reserve University School of Medicine joins us after her residency in Dermatology at Case Western; and Henry J. Votava, Ph.D., M.D., a graduate of the University of North Carolina, Chapel Hill where he earned a Ph.D. in Nuclear Physics as well. Henry was a Pathology resident at the University of Minnesota and has been a practicing pathologist in Fargo, North Dakota.

Dermatopharmacology Fellow:
Aieska Souza MD, who completed her Dermatology training in Brazil, comes to us following a research fellowship in Dermatology at the Mayo Clinic in Rochester, MN

Melanoma Research Fellow:
Heather Hamilton MD who comes to us following her internship in internal medicine at Baylor College of Medicine in Houston, TX

Pediatric Dermatology Fellow:
Harper Price MD, a graduate of Jefferson Medical College, is completing her Dermatology residency at Penn State in Hershey, PA

Procedural Dermatology Fellow:
Erica Lee MD, currently chief resident in the Dermatology program at New York Presbyterian, Weill Medical College of Cornell University

1)     Cutaneous T-Cell Lymphoma: CTCL-mycosis fungoides type
a.     Drug: Infusion medication of a fully human anti-CD4 antibody
b.     Duration (Approx): 12 weekly infusions, 8 week follow up
c.     Patient Population: Refractory/Intolerant to Targretin + 1 other standard         therapy

2)     Cutaneous T-Cell Lymphoma: Stage I and IIA ONLY
a.     Drug: Nitrogen Mustard Formulation-20 mg, 2 diff formulas
b.     Duration (Approx): 10 visits over 12 months (approx 1 per month)
c.     Patient Population: Must be naïve to NM or topical carmustine for 2 yrs

3)     Alopecia Areata
a.     Drug: Alefacept
b.     Duration: 12 weekly injections, 12 week follow-up
c.     Patient Population: Must have 50-95% patchy hair loss

4)     Psoriasis:
a.     Drug: Pt receives either of two medications previously shown to effectively tx         psoriasis
b.     Duration: 23 visits over 64 weeks
c.     Patient Population: 10% BSA +etanercept naïve

5)     Psoriasis:
a.     Drug: etanercept
b.     Duration: 5 yr study-observational post-marketing
c.     Patient Population: naive to etanercept, starts etanercept with         dermatologist, and followed for 5 yrs

For more information, please contact the Dermatopharmacology Unit at: 212.263.5244